Delivery Order SPE2DR25D3301-SPE2DR26F19MK
Award Date 12/12/25
Potential Completion Date 1/6/26
Potential Value $46K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Hemlibra 60 mg/0.4 ml vials, a specialized pharmaceutical product used in hemophilia treatment. This firm fixed-price delivery order, valued at $7,376.94, is scheduled for completion by January 6, 2026, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The award represents a competitive, non-set-aside procurement conducted under an existing contract vehicle,...
- The Defense Logistics Agency awarded a delivery order valued at $63,169.44 to AmerisourceBergen Drug Corp for the supply of HEMLIBRA 150 mg/ml vials. The contract is a firm fixed-price delivery order with an ultimate completion date of December 23, 2025, and represents a non-competitive, non-set-aside award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. This delivery order is issued under AmerisourceBergen's larger...
- This is a $24,673.08 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Hemlibra 105 mg/0.7 ml vials, a specialty medication. There is no set-aside designation, indicating this was an open competition. The contract has an ultimate completion date of March 31, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on October 31, 2025, for the supply of HEMLIBRA 105 mg/0.7 mL vials totaling $12,336.54, with completion scheduled for November 24, 2025. This is a firm fixed-price, non-set-aside contract performed at the vendor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of HEMLIBRA 105 mg/0.7 mL vials totaling $6,168.26. This is a firm fixed-price delivery order with no set-aside designation, demonstrating competitive award authority. The order is scheduled for completion by August 29, 2025, with performance taking place at AmerisourceBergen's corporate facility in Conshohocken, Pennsylvania. HEMLIBRA is a specialty pharmaceutical product...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of HEMLIBRA 105 MG/0.7 ML vials. This competitively awarded, non-set-aside contract has a ceiling value of $26,001.60 and is structured as a firm fixed price delivery order with an ultimate completion date of January 6, 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a single transaction...
- This federal contract award, with an ID of SPE2DX15D3020|SPE2DX24FXLKY, was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $33,409.40 Firm Fixed Price Delivery Order contract is for the supply of Hemlibra 150 mg/mL medication and has an ultimate completion date of March 4, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has an Indefinite Delivery Contract (IDC)...
- This federal contract award, valued at $16,704.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of HEMLIBRA 150 MG/ML VIALML. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of August 5, 2024. Amerisourcebergen Drug Corp, through its Corporate Office Division, has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $2,238.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Hemabate 250 mcg/mL ampules, with performance in Conshohocken, Pennsylvania and completion by December 3, 2025. This non-set-aside competitive award represents a pediatric and obstetric pharmaceutical product used for hemorrhage management. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency awarded a $1,271.85 firm fixed price delivery order to AmerisourceBergen Drug Corp for Hemabate 250 mcg/ml ampules, with an ultimate completion date of September 17, 2025. This non-set-aside contract represents a small-value pharmaceutical procurement delivered to the place of performance in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp fulfills this order under its...